CymitQuimica logo

MAGEA4 (230-239) Light

Ref. 3D-CRB1000938

1mg
254.00€
500µg
186.00€
MAGEA4 (230-239) Light
Biosynth

Product Information

Name:MAGEA4 (230-239) Light
Synonyms:
  • GVYDGREHTV-acidH-Gly-Val-Tyr-Asp-Gly-Arg-Glu-His-Thr-Val-OH
Brand:Biosynth
Description:Melanoma-associated antigen As (MAGEA) are a large family of tumour-associated antigens and a subclass of the larger family of cancer testis antigens (CTAs). These proteins are tumour antigens expressed in a variety of malignant tumours including: bladder- lung- skin and breast malignancies. In healthy tissue however their expression is restricted to germ cells of the testis, nervous system, foetal ovaries and placenta. In cancer cells, the MAGEA family proteins support growth, survival and metastasis, and contribute actively to malignancy. They are also involved in the regulation of the tumour suppressor protein p53 pathway and in regulating ubiquitin signalling in cancer cells. MAGEA expression is linked to poor prognosis in cancer patients. MAGEA subfamily proteins are recognized by cytotoxic T lymphocytes and evoke a strong T cell reactivity against autologous tumour cells in culture.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:1,131.5 g/mol
Formula:C48H73N15O17
Color/Form:Powder

Technical inquiry about: MAGEA4 (230-239) Light

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.